Product code QID— Microbiology

OraQuick Ebola Rapid Antigen Test

Classification name
Device To Detect Antigens Of Biothreat Microbial Agents In Human Clinical Specimens
Device class
Class 2
Regulation
21 CFR 866.4002
Advisory panel
Microbiology
Total cleared
1
First cleared
Most recent

FDA classification definition

“A device to detect antigens of biothreat microbial agents in human clinical specimens is identified as an in vitro diagnostic device intended for the detection of antigens of microbial agents in specimens collected from patients with signs and symptoms of infection with biothreat microbial agents and who have been exposed to these agents or are suspected or at risk of exposure.  Devices to detect antigens of biothreat microbial agents in human clinical specimens may be used for cadaver testing if the cadaver constitutes a source of human-to-human transmission and if testing is performed to prevent human disease.”

— U.S. Food and Drug Administration, device classification record for product code QID under 21 CFR 866.4002, via openFDA

Market context for product code QID

FDA has cleared 1 device under product code QID, all in 2019, filed by 1 applicant company. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Top applicants under product code QID

Recent clearances under product code QID

Data sourced from openFDA. This site is unofficial and independent of the FDA.